Tolusso, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 5.773
EU - Europa 4.400
AS - Asia 4.176
SA - Sud America 833
AF - Africa 139
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 8
AN - Antartide 2
Totale 15.343
Nazione #
US - Stati Uniti d'America 5.605
SG - Singapore 1.948
CN - Cina 987
DE - Germania 925
IT - Italia 817
BR - Brasile 679
SE - Svezia 596
PL - Polonia 528
FR - Francia 486
VN - Vietnam 375
GB - Regno Unito 207
IE - Irlanda 180
UA - Ucraina 169
IN - India 168
FI - Finlandia 148
HK - Hong Kong 124
ID - Indonesia 119
BD - Bangladesh 92
JP - Giappone 88
RU - Federazione Russa 81
CA - Canada 78
AR - Argentina 64
MX - Messico 58
TR - Turchia 55
NL - Olanda 51
BE - Belgio 49
IQ - Iraq 43
ZA - Sudafrica 39
KR - Corea 31
AT - Austria 29
CI - Costa d'Avorio 27
ES - Italia 23
VE - Venezuela 23
MA - Marocco 18
CH - Svizzera 16
CZ - Repubblica Ceca 16
PK - Pakistan 16
SA - Arabia Saudita 16
CO - Colombia 15
EC - Ecuador 15
IR - Iran 15
LT - Lituania 15
KE - Kenya 13
UZ - Uzbekistan 12
TN - Tunisia 11
PH - Filippine 10
IL - Israele 9
JO - Giordania 9
PE - Perù 9
PY - Paraguay 9
RO - Romania 9
AU - Australia 7
GR - Grecia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
CL - Cile 6
DZ - Algeria 6
EU - Europa 6
JM - Giamaica 6
NP - Nepal 6
CR - Costa Rica 5
EE - Estonia 5
LA - Repubblica Popolare Democratica del Laos 5
LV - Lettonia 5
PT - Portogallo 5
BG - Bulgaria 4
DK - Danimarca 4
HN - Honduras 4
HU - Ungheria 4
KH - Cambogia 4
LK - Sri Lanka 4
NG - Nigeria 4
SN - Senegal 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AM - Armenia 3
AO - Angola 3
AZ - Azerbaigian 3
EG - Egitto 3
ET - Etiopia 3
GA - Gabon 3
GE - Georgia 3
KG - Kirghizistan 3
MY - Malesia 3
PA - Panama 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AQ - Antartide 2
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
GH - Ghana 2
GT - Guatemala 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
MM - Myanmar 2
MT - Malta 2
Totale 15.314
Città #
Singapore 1.094
Chandler 640
Ashburn 561
San Jose 515
Warsaw 479
Beijing 197
Fairfield 191
New York 190
Rome 173
Ann Arbor 165
Dublin 165
Dearborn 150
Los Angeles 132
The Dalles 127
Wilmington 126
Ho Chi Minh City 125
Woodbridge 120
Seattle 113
Dallas 110
Hong Kong 110
Jakarta 110
Milan 107
Jacksonville 104
Nanjing 100
Lauterbourg 99
Munich 99
Hanoi 97
Hefei 97
San Mateo 94
Houston 88
Chicago 84
Cattolica 78
Tokyo 76
Frankfurt am Main 74
Boston 66
Helsinki 65
Cambridge 62
São Paulo 60
Bremen 51
Princeton 51
Marseille 44
Brussels 43
London 41
Santa Clara 40
Buffalo 37
Council Bluffs 37
Moscow 37
Boardman 32
North Bergen 32
Nürnberg 32
Lawrence 31
Redwood City 30
Izmir 29
Turku 28
Abidjan 27
Pune 27
Seoul 27
Nuremberg 24
St Louis 24
Denver 23
Montreal 23
Norwalk 23
Toronto 23
Kent 22
Kraków 22
Tianjin 22
Atlanta 21
Orem 21
Phoenix 21
Redmond 21
Chennai 20
Kunming 20
Lancaster 20
Mexico City 20
Nanchang 20
Haiphong 19
Paris 19
Baghdad 18
Lappeenranta 18
Amsterdam 17
Da Nang 17
Rio de Janeiro 17
Brasília 16
Hangzhou 16
Hebei 16
Johannesburg 16
Mountain View 15
San Francisco 15
Jiaxing 14
Leawood 14
Poplar 14
Portsmouth 14
Shenyang 14
Stockholm 14
Vienna 14
Brooklyn 13
Busto Arsizio 13
Curitiba 13
Roubaix 13
Santa Maria 13
Totale 8.491
Nome #
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 440
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 347
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 344
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 318
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 307
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 265
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 260
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 257
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 233
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 225
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 214
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 212
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 206
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 203
Malnutrition in COVID-19 survivors: prevalence and risk factors 200
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 198
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 195
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 194
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 188
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 181
COVID-19 atypical Parsonage-Turner syndrome: a case report 176
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 176
Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial 175
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 173
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 173
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 170
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 166
Sarilumab use in severe SARS-CoV-2 pneumonia 164
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 163
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 162
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 162
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 162
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 161
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 156
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 150
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 148
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 146
Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial 143
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 143
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 141
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 140
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 138
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 137
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 135
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 133
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 132
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 131
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 129
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 127
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 127
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 124
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 124
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 124
Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages 123
Beetroot juice intake positively influenced gut microbiota and inflammation but failed to improve functional outcomes in adults with long COVID: A pilot randomized controlled trial 123
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 123
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 123
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 120
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 120
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 120
Mitochondria-Derived Vesicles and Inflammatory Profiles of Adults with Long COVID Supplemented with Red Beetroot Juice: Secondary Analysis of a Randomized Controlled Trial 119
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 118
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 117
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 115
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 115
Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship? 114
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 113
Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis 112
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 112
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 109
Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve 106
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 105
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 104
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 104
Psoriatic arthritis and depressive symptoms: does systemic inflammation play a role? 103
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 102
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 102
Correction to: Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserve (Endocrine, (2019), 63, 2, (369-375), 10.1007/s12020-018-1783-1) 101
Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysis 100
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 99
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: A case report 99
Weight Loss, The Obesity Paradox in Rheumatoid Arthritis: Is It a Paradox? Comment on the Article by Baker et al 98
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study 98
Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patients: A Case-Control Study with Clinical, Hormonal, and Immunological Evaluation 96
Is it necessary to be citrullinated to have restricted clonotypes reacting with Collagen type II? Comment to article "A novel HLA-DRB1*10:01 restricted T cell epitope from citrullinated type II collagen relevant for Rheumatoid Arthritis" 96
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 96
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional Study. 95
The B side of rheumatoid arthritis pathogenesis 93
Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES 91
Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? 91
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 90
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy 89
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity 89
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 87
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons 86
Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis 86
Basophil activation and serum IL-5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti-IL-5 drugs 82
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 77
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER Study 76
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 76
Totale 14.711
Categoria #
all - tutte 65.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.104


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 0 0 29
2021/2022915 119 62 38 61 65 29 28 103 41 67 133 169
2022/20231.893 220 239 150 300 117 224 92 140 235 62 63 51
2023/20241.112 42 253 46 64 45 189 81 52 14 78 160 88
2024/20252.397 48 47 176 94 200 91 101 98 357 263 476 446
2025/20265.769 840 224 404 689 931 344 1.002 278 353 399 239 66
Totale 15.551